Masport® has been evaluated in multiple clinical studies and has over 12 years of market experience with more than 6 million injections administered. Phase III clinical studies have demonstrated that Masport® is as safe and effective as Dysport® for glabellar lines treatment. As with all medications, proper administration by qualified healthcare professionals and adherence to prescribing information is essential.